Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

TxA2 synthase inhibitor may have application in SAH

Sep. 8, 1999

N-(Phenylalkyl)cinnamides as structurally novel NR2B-selective NMDA receptor antagonists

Sep. 7, 1999

Plant-derived CNS stimulant and cognition-enhancing agent under study in Brazil

Sep. 6, 1999

Brain GABA-A receptor ligands developed by Neurogen scientists

Sep. 6, 1999

Zomig launched in China for treatment of migraine

Sep. 3, 1999

Potent new analgesic/antiinflammatory agents developed in China

Sep. 3, 1999

Results of SAR studies on PD-151307 analogues presented at ACS meeting

Sep. 3, 1999

German lab discovers novel potential antipsychotic agents: ustilipids

Sep. 3, 1999

Prodrugs of BK(Ca) channel modulators from BMS particularly useful for cerebral ischemia/stroke

Sep. 3, 1999

Potential antiparkinsonian agent emerges from series of subtype-selective NMDA receptor antagonists

Sep. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...